Dividend growth investing healthcare dividend growth investing

Healthcare dividend growth investing remains a defensive play amid market uncertainties. Pfizer’s recent 2.5% dividend boost, combined with pipeline expansion, aligns with investor demand for recession‑resilient income streams. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and EPR Properties wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. How can this be? Compare the top 10 constituents of the Morningstar US Dividend Growth Index to those of the broad equity market as represented by the Morningstar US Market Index. You’ll see how concentrated the “broad” market has become in key technology and tech-adjacent companies—only a few of which are dividend growers. Global dividend growth investing prospects are improving, especially in Asia‑Pacific markets. Data from MSCI shows dividend growth in emerging Asian companies at 5.6% CAGR, driven by manufacturing exports and supportive fiscal policy.